Keyphrases
Arteriovenous
100%
Stenosis
100%
Drug-eluting Balloon Angioplasty
100%
Hemodialysis Access
100%
Randomized Controlled Trial
66%
Restenosis
50%
Drug-coated Balloon
50%
Odds Ratio
33%
Primary Patency
33%
Target Lesion
33%
Arteriovenous Access
33%
Clinical Trials
16%
Literature Search
16%
Drug Use
16%
MEDLINE
16%
Embase
16%
Failure Rate
16%
Practice Guidelines
16%
Cochrane
16%
Non-drug
16%
Metaanalysis
16%
Drug Efficacy
16%
Intimal Hyperplasia
16%
Drug Safety
16%
Random Effects
16%
Balloon
16%
Late Failure
16%
Hemodialysis
16%
Alternative Interventions
16%
Major Complications
16%
Arteriovenous Fistula
16%
Percutaneous Intervention
16%
Minor Complications
16%
PRISMA
16%
Nonrandomized Studies
16%
Device Failure
16%
Percutaneous Management
16%
Angioplasty Balloon
16%
Steno-occlusive Disease
16%
Target Lesion Primary Patency
16%
Forward Citations
16%
Percutaneous Treatment
16%
Multiphysics Object-oriented Simulation Environment (MOOSE)
16%
PRISMA-P
16%
Backward Citations
16%
Local Drug Delivery
16%
Nursing and Health Professions
Systematic Review
100%
Percutaneous Transluminal Angioplasty
100%
Stenosis
100%
Hemodialysis
100%
Drug-Coated Balloon
100%
Cohort Analysis
50%
Restenosis
50%
Odds Ratio
33%
Diseases
33%
Practice Guideline
16%
Meta Analysis
16%
Guiding Catheter
16%
Medline
16%
Cochrane Library
16%
Drug Delivery System
16%
Arteriovenous Fistula
16%
Device Failure
16%
Hyperplasia
16%
Percutaneous Intervention
16%
Medicine and Dentistry
Systematic Review
100%
Stenosis
100%
Percutaneous Transluminal Angioplasty
100%
Hemodialysis
100%
Randomized Controlled Trial
66%
Cohort Analysis
50%
Restenosis
50%
Target Lesion
50%
Prosthetics
33%
Odds Ratio
33%
Diseases
33%
Clinical Trial
16%
Meta-Analysis
16%
Neointimal Hyperplasia
16%
Arteriovenous Fistula
16%
Percutaneous Intervention
16%
Device Failure
16%
Pharmacology, Toxicology and Pharmaceutical Science
Hemodialysis
100%
Stenosis
100%
Randomized Controlled Trial
66%
Cohort Study
50%
Restenosis
50%
Diseases
33%
Clinical Trial
16%
Hyperplasia
16%
Arteriovenous Fistula
16%